Breaking News Instant updates and real-time market news.

MRK

Merck

$66.21

0.34 (0.52%)

17:14
03/01/17
03/01
17:14
03/01/17
17:14

FDA approves Odactra to treat house dust mite nasal inflammation

The U.S. FDA approved Odactra, the first allergen extract to be administered under the tongue to treat house dust mite-induced nasal inflammation, with or without eye inflammation, in people 18 through 65 years of age. Odactra is manufactured for Merck, Sharp & Dohme Corp., (a subsidiary of Merck and Co., Whitehouse Station, N.J.) by Catalent Pharma Solutions Limited, United Kingdom. Reference Link

  • 02

    Mar

  • 08

    Mar

  • 15

    Mar

  • 01

    Apr

  • 10

    May

  • 27

    May

  • 14

    Jun

MRK Merck
$66.21

0.34 (0.52%)

01/24/17
LEHM
01/24/17
NO CHANGE
Target $58
LEHM
Equal Weight
Bristol-Myers price target lowered to $58 from $65 at Barclays
Barclays analyst Geoff Meacham lowered his price target for Bristol-Myers Squibb (BMY) to $58 after evaluating demand trends for the major immuno-oncology agents, namely Merck's (MRK) Keytruda, Bristol's Opdivo/Yervoy and Roche's (RHHBY) Tecentriq. Bristol's recent decision not to purse accelerated approval makes a premium to the group "harder to sustain absent convincing pivotal data," Meacham tells investors in a research note. The analyst keeps an Equal weight rating on the shares.
02/15/17
LEER
02/15/17
NO CHANGE
LEER
Biogen outlook intact despite Merck study suspension, says Leerink
Leerink analyst Geoffrey Porges notes that Merck (MRK) announced the suspension of the Phase 2/3 EPOCH trial of verubecestat in mild-to-moderate Alzheimer's patients for lack of efficacy, which was one of the most important catalysts for the field this year and a significant overhang for Biogen (BIIB) and other companies. While the failure had been widely anticipated in this study, the analyst believes this result does not read over to the outlook for Biogen's ongoing pivotal trials with aducanumab, or with its partner, Eisai's (ESALY) BACE inhibitor, elenbecestat.
02/24/17
RHCO
02/24/17
NO CHANGE
RHCO
Avadel Pharmaceuticals price target lowered to $13 from $17 at SunTrust
SunTrust analyst John Boris reduced his price target on Avadel (AVDL) after Endo (ENDP) launched an injectable drug that will compete, at a similar price point, with Avadel's Akovaz. The analyst adds that Avadel's Bloxiverz is also being challenged by Merck's (MRK) Bridion which is taking share in the neostigmine market. He lowered his estimates for Avadel below consensus levels but keeps a Buy rating on the name.
02/24/17
LEER
02/24/17
NO CHANGE
LEER
Merck write-down suggests 'rest of Idenix' is now 'very small,' says Leerink
Leerink analyst Geoffrey Porges notes that Merck (MRK) announced that it is taking a $2.9B impairment charge against the value of uprifosbuvir, or MK3682, which is the most important of the Hepatitis C nucleotide polymerase inhibitors it acquired from Idenix. The analyst believes this write-down suggests that the remaining value of the "rest of Idenix" is now very small. In addition to the delay for Merck's triple regimen, this impairment has "significant competitive implications" for Gilead (GILD) and AbbVie (ABBV), which are the most likely remaining participants in the HCV market, he adds.

TODAY'S FREE FLY STORIES

CO

China Cord Blood

$12.49

0.18 (1.46%)

06:45
08/24/17
08/24
06:45
08/24/17
06:45
Technical Analysis
Technical View: China Cord Blood hits new highs in pre-market »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

TIF

Tiffany

$88.72

0.22 (0.25%)

06:44
08/24/17
08/24
06:44
08/24/17
06:44
Hot Stocks
Tiffany provides FY17 outlook »

Management's outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:43
08/24/17
08/24
06:43
08/24/17
06:43
Hot Stocks
Tiffany sees FY17 CapEx $250M »

Sees FY17 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:42
08/24/17
08/24
06:42
08/24/17
06:42
Earnings
Tiffany sees FY17 EPS growth of high single digits, consensus $3.95 »

Sees FY17 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:40
08/24/17
08/24
06:40
08/24/17
06:40
Earnings
Tiffany reports Q2 adjusted EPS 92c, consensus 86c »

Reports Q2 revenue $960M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

HMLP

Hoegh LNG

$18.60

0.25 (1.36%)

06:38
08/24/17
08/24
06:38
08/24/17
06:38
Earnings
Hoegh LNG reports Q2 EPS 28c, consensus 40c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 12

    Sep

WDC

Western Digital

$88.31

1.66 (1.92%)

, TOSYY

Toshiba, also use TOSBF

$17.28

0.49 (2.92%)

06:38
08/24/17
08/24
06:38
08/24/17
06:38
Periodicals
Western Digital consortium to offer $17.4B for Toshiba chip unit, Reuters says »

A consortium that…

WDC

Western Digital

$88.31

1.66 (1.92%)

TOSYY

Toshiba, also use TOSBF

$17.28

0.49 (2.92%)

TOSBF

Toshiba, also use TOSYY

$2.88

0.064 (2.27%)

KKR

KKR

$18.57

-0.07 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXC

Exelon

$38.32

0.09 (0.24%)

06:36
08/24/17
08/24
06:36
08/24/17
06:36
Conference/Events
Exelon management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

06:35
08/24/17
08/24
06:35
08/24/17
06:35
General news
FX Action: USD-JPY has settled in the lower 109.0s »

FX Action: USD-JPY has…

DXLG

Destination XL

06:34
08/24/17
08/24
06:34
08/24/17
06:34
Conference/Events
Destination XL management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 31

    Aug

  • 28

    Sep

BDC

Belden

$73.25

0.08 (0.11%)

06:34
08/24/17
08/24
06:34
08/24/17
06:34
Conference/Events
Belden management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

  • 06

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:33
08/24/17
08/24
06:33
08/24/17
06:33
Hot Stocks
Hormel Foods acquires Ceratti brand for approximately $104M »

Hormel Foods announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:33
08/24/17
08/24
06:33
08/24/17
06:33
Earnings
Hormel cuts FY EPS view to $1.54-$1.58 from low end of $1.65-$1.71 »

Consensus is $1.65.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:32
08/24/17
08/24
06:32
08/24/17
06:32
Hot Stocks
Hormel Foods says faced 'record-high' input costs for two primary raw materials »

"We generated record…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

AVD

American Vanguard

$20.00

0.15 (0.76%)

06:32
08/24/17
08/24
06:32
08/24/17
06:32
Conference/Events
American Vanguard management to meet with Oppenheimer »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Earnings
Hormel Foods reports Q3 EPS 34c, consensus 37c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

WBC

Wabco

$138.46

0.22 (0.16%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Hot Stocks
Wabco to acquire Sheppard for $145M »

WABCO announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Sep

AIN

Albany International

$51.10

-0.2 (-0.39%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Conference/Events
Albany International management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

  • 01

    Sep

  • 28

    Sep

EADSY

Airbus

$20.89

-0.015 (-0.07%)

, DLAKY

Lufthansa

$24.60

-0.04 (-0.16%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Periodicals
European regulator, Airbus issue software fix for A350, Reuters reports »

The European Aviation…

EADSY

Airbus

$20.89

-0.015 (-0.07%)

DLAKY

Lufthansa

$24.60

-0.04 (-0.16%)

SINGY

Singapore Airlines

CPCAY

Cathay Pacific

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTD

L Brands

06:30
08/24/17
08/24
06:30
08/24/17
06:30
Conference/Events
L Brands to host sales conference call »

Pre-Recorded August sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

06:30
08/24/17
08/24
06:30
08/24/17
06:30
General news
FX Action: USD-JPY has settled in the lower 109.0s »

FX Action: USD-JPY has…

BRCD

Brocade

$12.25

0.06 (0.49%)

, AVGO

Broadcom

$256.92

1.73 (0.68%)

06:22
08/24/17
08/24
06:22
08/24/17
06:22
Hot Stocks
China conditionally approves Broadcom's proposed acquisition of Brocade »

In a regulatory filing,…

BRCD

Brocade

$12.25

0.06 (0.49%)

AVGO

Broadcom

$256.92

1.73 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 24

    Aug

FB

Facebook

$168.71

-0.93 (-0.55%)

06:20
08/24/17
08/24
06:20
08/24/17
06:20
Periodicals
Facebook taps exec Andrew Bosworth to lead hardware efforts, BI reports »

Facebook has selected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 13

    Sep

GOOG

Alphabet

$927.00

2.31 (0.25%)

, GOOGL

Alphabet Class A

$942.58

2.18 (0.23%)

06:20
08/24/17
08/24
06:20
08/24/17
06:20
Periodicals
Google could unveil new Pixel phones on October 5, Engadget reports »

Google (GOOG) could…

GOOG

Alphabet

$927.00

2.31 (0.25%)

GOOGL

Alphabet Class A

$942.58

2.18 (0.23%)

QCOM

Qualcomm

$52.23

-0.12 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

NADL

North Atlantic Drilling

$1.19

0.02 (1.71%)

06:17
08/24/17
08/24
06:17
08/24/17
06:17
Earnings
North Atlantic Drilling reports Q2 EPS ($2.59), consensus ($2.97) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.